Trials / Unknown
UnknownNCT05351385
S Protein and COVID-19: a Monocentric Prospective Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- University of Milano Bicocca · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare plasma S Protein levels to SARS-CoV-2 viral load in COVID positive patients.
Detailed description
Non-pharmacological, non-interventional, prospective, monocentric study involving the use of biological materials. There will be two cohorts: * COVID + cohort: 50 patients with positive nasopharyngeal swab and / or BAL. * Control Cohort: 20 patients with non-SARS-CoV-2 related pneumonia. The study involves analyzing biological samples collected for normal clinical practice. In particular: * blood samples will be used for PROS and Sflt1 assay, haematological, biochemical and coagulation tests. * Samples deriving from nasopharyngeal swab or from Broncho-Alveolar Lavage (BAL) liquid will be used for Real time PCR analysis to evaluate the viral load of SARS CoV-2.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hematolgy and Chemistry analysis | Samples will be collected at Day 0, Day 5, Day 10 and Day 15 |
| PROCEDURE | Real Time PCR | Samples will be collected at Day 0, Day 5, Day 10 and Day 15 |
| PROCEDURE | PROS assay COVID+ | Samples will be collected at Day 0, Day 5, Day 10 and Day 15 |
| PROCEDURE | Sflt1 assay COVID+ | Samples will be collected at Day 0 and Day 10 |
| PROCEDURE | PROS assay CONTROL | Samples will be collected at Day 0 (+5) |
| PROCEDURE | Sflt1 assay CONTROL | Samples will be collected at Day 0 (+5) |
Timeline
- Start date
- 2021-09-23
- Primary completion
- 2022-06-03
- Completion
- 2024-12-03
- First posted
- 2022-04-28
- Last updated
- 2024-01-02
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05351385. Inclusion in this directory is not an endorsement.